Index by author

September 1, 2021; Volume 62,Issue 9

  1. Gafita, Andrei

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931

  2. Gardner, Linda

    1. The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
      Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1244-1251; DOI: https://doi.org/10.2967/jnumed.120.257931

  3. Glaudemans, Andor W.J.M.

    1. Value of <sup>18</sup>F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study
      Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers and Carolina P. Schröder
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1214-1220; DOI: https://doi.org/10.2967/jnumed.120.256826

  4. Goldenberg, David M.

    1. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study
      Caroline Bodet-Milin, Alain Faivre-Chauvet, Thomas Carlier, Catherine Ansquer, Aurore Rauscher, Eric Frampas, Frederique Toulgoat, Damien Masson, Mickael Bourgeois, Evelyne Cerato, Vincent Rohmer, Olivier Couturier, Delphine Drui, David M. Goldenberg, Robert M. Sharkey, Jacques Barbet and Francoise Kraeber-Bodere
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1221-1227; DOI: https://doi.org/10.2967/jnumed.120.252791

  5. Gordon, Leonie L.

    1. Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors
      Jocelyn L. Cheng, Elizabeth H. Dibble, Grayson L. Baird, Leonie L. Gordon and Hyewon Hyun
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1207-1213; DOI: https://doi.org/10.2967/jnumed.120.260711

  6. Gorin, Michael A.

    1. Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
      Mark C. Markowski, Pedro Isaacsson Velho, Mario A. Eisenberger, Martin G. Pomper, Kenneth J. Pienta, Michael A. Gorin, Emmanuel S. Antonarakis, Samuel R. Denmeade and Steven P. Rowe
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1270-1273; DOI: https://doi.org/10.2967/jnumed.120.259226

  7. Gosmann, Dario

    1. Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
      Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384

  8. Gotthardt, Martin

    1. Head-to-Head Comparison of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Open Access
      Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients
      Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah and Martin Gotthardt
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1258-1263; DOI: https://doi.org/10.2967/jnumed.120.258541

  9. Gourni, Eleni

    1. Combination of Forced Diuresis with Additional Late Imaging in <sup>68</sup>Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
      Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger and Ali Afshar-Oromieh
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1252-1257; DOI: https://doi.org/10.2967/jnumed.120.257741

  10. Graves, Stephen

    1. Addition of <sup>131</sup>I-MIBG to PRRT (<sup>90</sup>Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      Open Access
      Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
      David L. Bushnell, Kellie L. Bodeker, Thomas M. O’Dorisio, Mark T. Madsen, Yusuf Menda, Stephen Graves, Gideon K.D. Zamba and M. Sue O’Dorisio
      Journal of Nuclear Medicine September 1, 2021, 62 (9) 1274-1277; DOI: https://doi.org/10.2967/jnumed.120.254987
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue